中国医药导报
中国医药期刊欢迎您 今天是   2025年4月8日星期二
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  临床研究 本期目录 | 过刊浏览 | 高级检索 |
血尿酸/肌酐比值和N-末端脑钠肽前体水平在慢性阻塞性肺疾病急性加重期患者预后判断中的应用价值
王丽兵1      张晓东1      张贵荣1      丁一红2
1.安徽省天长市中医院呼吸科,安徽天长   239300;
2.安徽省阜阳市人民医院急诊科,安徽阜阳   236000
Application value of serum uric acid / creatinine ratio and N-terminal pro-brain natriuretic peptide level in prognosis of patients with acute exacerbation of chronic obstructive pulmonary disease
WANG Libing1   ZHANG Xiaodong1   ZHANG Guirong1   DING Yihong2
1.Department of Pneumology, Tianchang Hospital of Traditional Chinese Medicine, Anhui Province, Tianchang   239300, China; 
2.Department of Emergency, Fuyang People’s Hospital, Anhui Province, Fuyang   236000, China
全文: PDF (698 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探究血尿酸(UA)/肌酐(Cr)比值和N-末端脑钠肽前体(NT-proBNP)水平在慢性阻塞性肺疾病急性加重期(AECOPD)患者预后判断中的应用价值。 方法 选取2018年10月至2020年10月安徽省天长市中医院收治的82例AECOPD患者为研究对象,均完成12个月的随访。根据预后情况将其分为死亡组(10例)和存活组(72例),比较两组血UA/Cr、NT-proBNP水平,分析AECOPD患者预后的影响因素,以及血UA/Cr、NT-proBNP水平评价AECOPD预后的价值。 结果 本研究中AECOPD患者死亡率为12.20%。死亡组急性生理和慢性健康状况Ⅱ(APACHEⅡ)评分、NT-proBNP、血UA/Cr水平及病情为Ⅳ级占比均高于存活组(P < 0.05)。多因素分析显示,APACHEⅡ评分、NT-proBNP、血UA/Cr、病情为Ⅳ级均是AECOPD患者死亡的影响因素(P < 0.05)。血UA/Cr和NT-proBNP水平联合预测AECOPD患者死亡的受试者操作特征曲线下面积大于二者单独预测(P < 0.05)。结论 血UA/Cr和NT-proBNP与AECOPD患者预后关系密切,两者单独及联合检测对患者的预后均有较高的预测效能,且血UA/Cr联合NT-proBNP的预测效能更高。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
王丽兵1 张晓东1 张贵荣1 丁一红2
关键词 慢性阻塞性肺疾病急性加重期血尿酸/肌酐比值    
Abstract:Objective To explore the application value of serum uric acid (UA) / creatinine (CR) ratio and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels in predicting the prognosis of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods A total of 82 patients with AECOPD admitted to Tianchang Hospital of Traditional Chinese Medicine, Anhui Province from October 2018 to October 2020 were selected as the study object, all patients were followed up for 12 months. According to the prognosis, they were divided into death group (10 cases) and survival group (72 cases). Serum UA / Cr and NT-proBNP levels of the two groups were compared to analyze the factors influencing the prognosis of AECOPD patients, and the value of serum UA / Cr and NT-proBNP levels in evaluating the prognosis of AECOPD. Results The mortality rate of AECOPD patients in this study was 12.20%. The levels of acute physiology and chronic health evaluation Ⅱ(APACHE Ⅱ) score, NT-proBNP, serum UA / Cr, and the proportion of Grade Ⅳ in death group were higher than those in survival group (P < 0.05). Multivariate analysis showed that APACHE Ⅱ score, NT-proBNP, serum UA / Cr, and Grade Ⅳ were the influencing factors of death in AECOPD patients (P < 0.05). Serum UA / Cr and NT-proBNP levels combined to predict the death of AECOPD patients had a higher area under the receiver operating characteristic curve than those predicted separately (P < 0.05). Conclusion Serum UA / Cr and NT-proBNP are closely related to the severity and prognosis of AECOPD patients. Both alone and combined tests have high prognostic efficacy, and serum UA / Cr combined with NT-proBNP have higher prognostic efficacy.
Key wordsChronic obstructive pulmonary disease    Acute exacerbation    Serum uric acid / creatinine ratio
    
基金资助:安徽省医学会急诊临床研究项目(Ky2018014)。
作者简介: 王丽兵(1977.2-),男,副主任医师;研究方向:阻塞性肺疾病、肺肿瘤。
引用本文:   
王丽兵1 张晓东1 张贵荣1 丁一红2. 血尿酸/肌酐比值和N-末端脑钠肽前体水平在慢性阻塞性肺疾病急性加重期患者预后判断中的应用价值[J]. 中国医药导报, 2022, 19(23): 117-120.
WANG Libing1 ZHANG Xiaodong1 ZHANG Guirong1 DING Yihong2. Application value of serum uric acid / creatinine ratio and N-terminal pro-brain natriuretic peptide level in prognosis of patients with acute exacerbation of chronic obstructive pulmonary disease. 中国医药导报, 2022, 19(23): 117-120.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/     或     https://www.yiyaodaobao.com.cn/CN/Y2022/V19/I23/117

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司